Beyfortus (Nirsevimab) is a monoclonal antibody against the Respiratory Syncytial Virus (RSV). It provides immunity to RSV like a vaccine, though it works in a different way. Beyfortus reduces hospitalizations and death in babies <8 months with RSV by up to 80%. It is recommended by the FDA, CDC, and all of us at Potomac Pediatrics.
When should my baby get Beyfortus?
- Newborns born from October – March should receive a dose within their first week of life
- Babies less than 8 months born before October should receive a dose ASAP this fall
Due to the cost of the vaccine, once paid and scheduled this fee is non-refundable.
WE HAVE LIMITED BEYFORTUS DOSES LEFT AND ARE NOT ACCEPTING NEW APPLICATIONS AT THIS TIME!